These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet-derived growth factor-induced p21ras-mediated signaling is independent of platelet-derived growth factor receptor interaction with GTPase-activating protein or phosphatidylinositol-3-kinase. Burgering BM; Freed E; van der Voorn L; McCormick F; Bos JL Cell Growth Differ; 1994 Mar; 5(3):341-7. PubMed ID: 8018566 [TBL] [Abstract][Full Text] [Related]
3. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium. Dabrow MB; Francesco MR; McBrearty FX; Caradonna S Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315 [TBL] [Abstract][Full Text] [Related]
4. [Relationship of platelet-derived growth factor with benign prostatic hyperplasia]. Chu J; Zhong HX Zhonghua Nan Ke Xue; 2007 Oct; 13(10):932-5. PubMed ID: 17977330 [TBL] [Abstract][Full Text] [Related]
6. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor. Keyes LE; Moore LG; Walchak SJ; Dempsey EC J Cell Physiol; 1996 Jan; 166(1):22-32. PubMed ID: 8557771 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716. Major TC; Keiser JA J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349 [TBL] [Abstract][Full Text] [Related]
8. High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Di Paolo S; Gesualdo L; Ranieri E; Grandaliano G; Schena FP Am J Pathol; 1996 Dec; 149(6):2095-106. PubMed ID: 8952542 [TBL] [Abstract][Full Text] [Related]
9. Density-dependent inhibitory effect of transforming growth factor-beta 1 on human fibroblasts involves the down-regulation of platelet-derived growth factor alpha-receptors. Paulsson Y; Karlsson C; Heldin CH; Westermark B J Cell Physiol; 1993 Oct; 157(1):97-103. PubMed ID: 8408247 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry analysis of platelet-derived growth factor A and B chains and platelet-derived growth factor alpha and beta receptor expression in benign prostatic hyperplasias and Gleason-graded human prostate adenocarcinomas. Fudge K; Wang CY; Stearns ME Mod Pathol; 1994 Jun; 7(5):549-54. PubMed ID: 7524068 [TBL] [Abstract][Full Text] [Related]
11. Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. Choudhury GG; Grandaliano G; Jin DC; Katz MS; Abboud HE Kidney Int; 2000 Mar; 57(3):908-17. PubMed ID: 10720944 [TBL] [Abstract][Full Text] [Related]
12. Evidence for functional platelet-derived growth factor receptors on MG-63 human osteosarcoma cells. Graves DT; Antoniades HN; Williams SR; Owen AJ Cancer Res; 1984 Jul; 44(7):2966-70. PubMed ID: 6327031 [TBL] [Abstract][Full Text] [Related]
13. [Benign prostatic hyperplasia and growth factors: mechanisms and hypotheses]. Aumüller G Urologe A; 1992 May; 31(3):159-65. PubMed ID: 1377433 [TBL] [Abstract][Full Text] [Related]
14. Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. Gleason PE; Jones JA; Regan JS; Salvas DB; Eble JN; Lamph WW; Vlahos CJ; Huang WL; Falcone JF; Hirsch KS J Urol; 1993 Jun; 149(6):1586-92. PubMed ID: 7684794 [TBL] [Abstract][Full Text] [Related]
15. Influence of suramin alone or in combination with DHT and PDGF on the cell proliferation of benign and malignant human prostatic tissues in organ cultures. Michel P; Van Velthoven R; Petein M; Gras S; Etievant C; Pasteels JL; Kiss R Anticancer Res; 1991; 11(6):2075-8. PubMed ID: 1723262 [TBL] [Abstract][Full Text] [Related]
16. Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines. Sitaras NM; Sariban E; Bravo M; Pantazis P; Antoniades HN Cancer Res; 1988 Apr; 48(7):1930-5. PubMed ID: 2832055 [TBL] [Abstract][Full Text] [Related]
17. PDGF-mediated activation of phosphatidylinositol 3 kinase in human mesangial cells. Choudhury GG; Biswas P; Grandaliano G; Fouqueray B; Harvey SA; Abboud HE Kidney Int; 1994 Jul; 46(1):37-47. PubMed ID: 7933847 [TBL] [Abstract][Full Text] [Related]
18. Suramin binds to platelet-derived growth factor and inhibits its biological activity. Hosang M J Cell Biochem; 1985; 29(3):265-73. PubMed ID: 4077932 [TBL] [Abstract][Full Text] [Related]
19. Regulation of rat testis gonocyte proliferation by platelet-derived growth factor and estradiol: identification of signaling mechanisms involved. Li H; Papadopoulos V; Vidic B; Dym M; Culty M Endocrinology; 1997 Mar; 138(3):1289-98. PubMed ID: 9048638 [TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Marra F; Gentilini A; Pinzani M; Choudhury GG; Parola M; Herbst H; Dianzani MU; Laffi G; Abboud HE; Gentilini P Gastroenterology; 1997 Apr; 112(4):1297-306. PubMed ID: 9098016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]